EU
Poland and Slovenia included in US-EU mutual recognition agreement
February 20, 2019Research and Development EU, GMP, Poland, Slovenia, USA, mutual recognition
Poland and Slovenia have been deemed capable of carrying out Good Manufacturing Practice (GMP) inspections at an equivalent level to …
FMD would not apply in case of no-deal Brexit
February 8, 2019Medical Communications EU, FMD, UK, brexit, falsified medicines
The Falsified Medicines Directive would be scrapped in the event of a no deal Brexit, the Association of the British …
400 Pfizer employees set to strike over pensions
February 1, 2019Medical Communications EU, Ireland, Little Island, Pfizer, Ringaskiddy, SITPU, strike
400 Pfizer employees are set to go on strike in Ireland over an ongoing pensions dispute. Members of SITPU, Ireland’s …
Novartis warns of huge impact of no-deal Brexit
January 28, 2019Sales and Marketing EU, Novartis, UK, brexit, no-deal, pharma
Swiss pharmaceutical company Novartis has called on the British government to ‘ensure continuity of supply’ in the case of a …
EMA approves more new active substances in 2018, but total recommendations fall
January 14, 2019Sales and Marketing EMA, EU, Europe, drug approvals, pahrma
2018 was a strong year for European approvals according to the EMA; the regulator has recently released its Human medicines …
Pfizer announces new UK Managing Director
December 10, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ben Osborne, EU, Leeds, Pfizer, sales
New York City-based multinational Pfizer has announced the appointment of Ben Osborn to the role of managing Director in the …
Working Life: Kai Gait, Senior Global Digital Director at GlaxoSmithKline
December 6, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, GSK, Interview, UK, US, digital, senior global director, technology
Kai Gait, Senior Global Digital Director at GlaxoSmithKline, retraces the steps that have led him to where he is today, …
Shire’s Takhzyro scores EU approval in rare genetic disorder hereditary angioedema
December 3, 2018Sales and Marketing EU, Europe, Shire, Takhzyro, pharma
Shire has announced that it has secured European approval for its subcutaneous injection Takhzyro (lanadelumab) for the routine prevention of …
MSD chalks up two HIV drug approvals in Europe
November 30, 2018Medical Communications, Sales and Marketing Delstrigo, EU, Europe, HIV, MSD, Pifeltro, pharma
MSD has announced the European approval of two of its products for the treatment of HIV: the single-tablet combination Delstrigo …
Mundipharma’s Neulasta biosimilar approved in EU
November 26, 2018Sales and Marketing Amgen, EU, Europe, Mundipharma, Neulasta, Pelmeg, pharma
Mundipharma has revealed that Pelmeg, its biosimilar version of Amgen’s Neulasta (pegfilgrastim), has been awarded marketing approval by the European …
Novartis’ gene therapy Luxturna becomes first approved European therapy for vision loss subtype
November 23, 2018Medical Communications, Sales and Marketing EU, Europe, Luxturna, Novartis, pharma, vision loss
Novartis has revealed that its one-time gene therapy Luxturna (voretigene neparvovec) has been awarded approval by the European Commission to …
Eli Lilly’s Emgality cleared for treatment of migraine in Europe
November 20, 2018Manufacturing and Production, Sales and Marketing EU, Eli Lilly, Emgality, Europe, migraine, pharma
Eli Lilly’s Emgality (galcanezumab) has secured approval from the European Commission for the prophylaxis of migraine in adult patients who …
EU rules may be stifling Britain’s biotech industry
November 19, 2018Sales and Marketing EU, biotech, britain, funding, grants, industry
EU rules are stifling Britain’s biotech industry, according to companies who talked to British newspaper The Daily Telegraph. The newspaper …
The November 2018 issue of Pharmafocus is available to read online now!
November 6, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, President trump, Trump, anti vaxxer, brexit, clinical trials, opioid crisis, opioids, pharma, vaccines
As the US continues to battle the demons in its healthcare system, Donald Trump looks like he may finally make …
Top Ten most popular articles on Pharmafile.com this week
October 5, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, Jannsen, NHS, Novartis, Novo Nordisk, dementia, top 10
As September came to a close and October began the UK was hit hard in the headlines after American firm …
Latest content
